1755-04-0

Basic information

• Product Name: Bicyclo[3.1.0]hexan-3-one
• Synonyms: Bicyclo[3.1.0]hexan-3-one;Cis-Bicyclo[3.1.0]Hexan-3-One
• CAS NO: 1755-04-0
• Molecular Formula: C₆H₈O
• Molecular Weight: 96.13
• Mol File: 1755-04-0.mol

Chemical Properties

• Boiling Point: 54-55 °C(Press: 25 Torr)
• Appearance: /
• Density: 1.144±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: Bicyclo[3.1.0]hexan-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: Bicyclo[3.1.0]hexan-3-one(1755-04-0)
• EPA Substance Registry System: Bicyclo[3.1.0]hexan-3-one(1755-04-0)

Safety Data

• Hazardous Substances Data: 1755-04-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Bicyclo[3.1.0]hexan-3-one is used as a starting material for the synthesis of various pharmaceuticals due to its unique bicyclic structure and chemical reactivity, enabling the development of new and effective medications.
Used in Fragrance and Flavor Industry:
Bicyclo[3.1.0]hexan-3-one is used as a component in the production of fragrances and flavors for its pleasant scent, enhancing the sensory experience of consumer products.
Used in Organic Synthesis:
Bicyclo[3.1.0]hexan-3-one is used as a versatile building block in organic chemistry for its complex and unique chemical reactivity, facilitating the creation of diverse organic compounds for various applications.

Upstream product

• 694-43-9 (1R,3r,5S)-bicyclo[3.1.0]hexan-3-ol 
• 89489-26-9 (1R,5S)-bicyclo[3.1.0]hexan-3-ol 
• 14320-38-8 cyclopent-3-enol 
• 89489-26-9 bicyclo[3.1.0]hexane-3-ol 
• 285-58-5 bicyclo[3.1.0]hexane 
• 16782-45-9 3-Methylen-bicyclo<3.1.0>hexan 

Downstream Products

• 114200-22-5 3-phenyl-3-cyanobicyclo<3.1.0>hexane 
• 71194-15-5 trans-3-phenylbicyclo<3.1.0>hexan-3-ol 
• 591-93-5 1,4-Pentadiene 
• 114200-21-4 trans-2-phenyl-2-(N-piperidinyl)bicyclo<3.1.0>hexane 
• 114200-20-3 cis-2-phenyl-2-(N-piperidinyl)bicyclo<3.1.0>hexane 
• 114200-25-8 trans-3-phenyl-3-aminobicyclo<3.1.0>hexane 
• 114200-24-7 cis-3-phenyl-3-aminobicyclo<3.1.0>hexane 
• 75296-10-5 1-methylcyclohexenyl cation 

Relevant articles and documents

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula I.

N-SUBSTITUTED-4-OXO-3,4-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-2-YL DERIVATIVES AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth Formula I.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds and pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.

N-SUBSTUTUTED-6-OXO-1,6-DIHYDROPYRIMIDINE-2-YL DERIVATIVES AS INHIBITORS OF THE HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula I

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

A compound of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: (I)

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: (I)

PYRAZOLE CARBOXAMIDE COMPOUNDS FOR TREATMENT OF HBV

The present disclosure provides, in part, pyrazole carboxamide compounds, and pharmaceutical compositions thereof, useful for disruption of HBV core protein assembly, and methods of treating Hepatitis B (HBV) infection.

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

A pharmaceutical composition comprising the compound of Formula Ia, Formula Ib, Formula Ic, or Formula Id, or a pharmaceutically acceptable salt thereof, is set forth. (Formula Ia), (Formula Ib), (Formula Ic), (Formula Id)

QUINAZOLINYL-INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth: Formula (I):

INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION

Compounds of Formula (I), including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth.